Ping Yi

9PUBLICATIONS
43CO-AUTHORS
Molecular targetsPredictive and prognostic markersNoise and wave pollution processes and measurementNanoscale characterisationMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 25, 2026
Targeting ADAR1 lactylation activates innate immune and overcomes chemoresistance in ovarian cancer.

|Dec 01, 2025
ALYREF condensation stabilizes m5C-modified PARP10 mRNA and promotes PI3K-AKT signaling in ovarian cancer.

Hongyan Zhao, Qinglv Wei, Zhi Luo

|Sep 16, 2025
Prenatal PM2.5 Exposure Induces Offspring Hypertension via Nrf2/NLRP3 Pathway.

Xinyuan Zhang, Boping Yang, Mengyuan Li

|Aug 07, 2025
SRSF9 Forms Phase-Separated Condensates to Promote Ovarian Cancer Progression by Inducing RNA Alternative Splicing That Is Inhibited by m6A Modification.

Xinzhao Zuo, Jie Xu, Dan Yang

|Jul 09, 2025
IGF2BP2 binding to CPSF6 facilitates m6A-mediated alternative polyadenylation of PUM2 and promotes malignant progression in ovarian cancer.

Xin Luo, Qinglv Wei, Lingcui Xie

|Apr 29, 2025
IGF2BP3 recruits NUDT21 to regulate SPTBN1 alternative polyadenylation and drive ovarian cancer progression.

Xin Luo, Lingcui Xie, Xiaohui Ma

Pageof 2

Frequent Collaborators

5 joint publications

Tao Liu

2 joint publications

Wei Wang

2 joint publications

Qinglv Wei

2 joint publications

Jing Xu